bronchial asthma
Conditions
Interventions
Control group:Basic Western medical treatment
Intervention group:Western medicine basic treatment + si zi ding
Sponsors
Urumqi Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Aged =18 and =75 years; 2.Meeting diagnostic criteria from: 2024 GINA MAIN REPORT Chinese Guidelines for Bronchial Asthma Prevention and Treatment (2020 Edition) Chinese Expert Consensus on Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Bronchial Asthma Diagnosis and Treatment Research of Northwest Dryness Syndrome; 3.Not participating in other clinical trials and having signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with combined pulmonary diseases such as pulmonary fibrosis bronchiectasis chronic obstructive pulmonary disease lung tumors tuberculosis and asthmatic bronchitis; 2. Patients with severe dysfunction of the heart liver or kidneys or with coagulation disorders; 3. Cancer patients patients with mental illness and those with communication and cognitive impairments; 4. Women who are pregnant or breastfeeding; 5. Those allergic to the known drug components of this study; 6. Those using other Chinese patent medicines.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom relief time (wheezing, shortness of breath and chest tightness);Pulmonary function (FVC, FEV1, PEF); | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage and total number of eosinophils in peripheral blood;Determination of nitric oxide exhalation;Systemic inflammation level (IL4, IL13, IL17, IL33);Asthma Control Level;The number of acute aggravations;Northwest Dry Syndrome Score Table; | — |
Countries
China
Contacts
Public ContactDe Jiang
Xinjiang Medical University School of Traditional Chinese Medicine
Outcome results
None listed